Dostarlimab
Product Specifications
CAS Number
2022215-59-2
Target
PD-1/PD-L1
Related Pathways
Cell Cycle/Checkpoint, Apoptosis, Immunology/Inflammation
Purity
0.9892
Bioactivity
Dostarlimab (TSR-042) is a programmed cell death protein 1 (PD-1) receptor immune checkpoint inhibitor that blocks interactions with PD-L1 and PD-L2, used in the study of endometrial cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0009207-01 10 µg
Recombinant Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)
Sign In for Pricing
View Details TRV-0009207-02 50 µg
Recombinant Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)
Sign In for Pricing
View Details TRV-0009207-03 100 µg
Recombinant Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)
Sign In for Pricing
View Details TRV-0009207-04 200 µg
Recombinant Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)
Sign In for Pricing
View Details TRV-0009207-05 500 µg
Recombinant Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)
Sign In for Pricing
View Details TRV-0009207-06 1 mg
Recombinant Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)
Sign In for Pricing
View Details